Peer-led, Mobile App Supported Linkage to Opioid Use Disorder Treatment
Public ClinicalTrials.gov record NCT07900828. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
mPeer4Life: A Peer-led, Mobile Health-supported, Narrative-based Intervention to Enhance Linkage and Engagement in Medication Assisted Treatment (MAT) for Patients With Opioid Use Disorder (OUD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is the third phase of the mPeer4Life study - the Trial Phase, will be evaluating the intervention that was developed based on the Formative and Pilot Phases. The study population are patients transitioning from the Emergency Department (ED) or hospital to outpatient Medication Assisted Treatment (MAT). The RCT will consist of three arms (1:1:1) with 30 participants in each arm: * Arm 1 will include a peer navigator + mobile phone-assisted intervention * Arm 2 will have a peer navigator only * Arm 3 will follow the standard of care referral for MAT linkage All patient-level participants will complete baseline and exit interviews, which will evaluate current drug use behaviors, medical history, and OUD treatment engagement status.
Study identification
- NCT ID
- NCT07900828
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 90 participants
Conditions and interventions
Conditions
Interventions
- Mobile phone-assisted intervention Behavioral
- Peer navigator Behavioral
- Standard of care referral for out-patient MAT Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 1, 2027 (Estimated)
- Primary completion
- Dec 31, 2029 (Estimated)
- Completion
- Jun 30, 2030 (Estimated)
- Last update posted
- Oct 28, 2026
2027 – 2030
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Johns Hopkins Hospital | Baltimore | Maryland | 21287 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07900828, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 28, 2026 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07900828 live on ClinicalTrials.gov.